Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 7
2004 5
2005 5
2006 6
2007 2
2008 6
2009 7
2010 7
2011 13
2012 7
2013 4
2014 11
2015 11
2016 21
2017 9
2018 15
2019 27
2020 18
2021 26
2022 28
2023 27
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Control Compounds for Preclinical Drug-Induced Liver Injury Assessment: Consensus-driven systematic review by the ProEuroDILI Network.
Segovia-Zafra A, Villanueva-Paz M, Serras AS, Matilla-Cabello G, Bodoque-García A, Di Zeo-Sánchez D, Niu H, Álvarez-Álvarez I, Sanz-Villanueva L, Godec S, Milisav I, Bagnaninchi P, Andrade RJ, Lucena MI, Fernández-Checa JC, Cubero FJ, Miranda JP, Nelson LJ. Segovia-Zafra A, et al. Among authors: andrade rj. J Hepatol. 2024 May 2:S0168-8278(24)00325-8. doi: 10.1016/j.jhep.2024.04.026. Online ahead of print. J Hepatol. 2024. PMID: 38703829
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.
Ruiz-Cobo JC, Llaneras J, Forns X, Gallego Moya A, Conde Amiel I, Arencibia A, Diago M, García-Samaniego J, Castellote J, Llerena S, Rodríguez-Seguel E, Mateos B, Rodríguez M, Rosales Zabal JM, Fernández I, Calleja JL, Morillas RM, Montoliu S, Andrade RJ, Badia Aranda E, Hernández-Guerra M, Maté CJ, González-Santiago JM, de Cuenca B, Bernal-Monterde V, Delgado M, Turnes J, Lens S, Buti M. Ruiz-Cobo JC, et al. Among authors: andrade rj. Aliment Pharmacol Ther. 2024 May 2. doi: 10.1111/apt.18020. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38695095
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
Ampuero J, Aller R, Gallego-Durán R, Crespo J, Calleja JL, García-Monzón C, Gómez-Camarero J, Caballería J, Lo Iacono O, Ibañez L, García-Samaniego J, Albillos A, Francés R, Fernández-Rodríguez C, Maya-Miles D, Diago M, Poca M, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Hernández-Guerra M, Pareja-Megia MJ, Banales JM, Aspichueta P, Benlloch S, Rosales JM, Turnes J, Romero-Gómez M; HEPAmet Registry. Ampuero J, et al. Among authors: andrade rj. J Gastroenterol. 2024 Apr 15. doi: 10.1007/s00535-024-02098-8. Online ahead of print. J Gastroenterol. 2024. PMID: 38619600
Hepatitis C virus point-of-care microelimination approach in a vulnerable population in the South of Spain.
Pinazo-Bandera JM, Aranda J, García-García AM, Alcántara R, Ortega-Alonso A, Del Campo-Herrera E, Clavijo E, García-Escaño MD, Ruiz Ruiz JJ, Morales-Herrera M, Valle-López V, Martín-Alarcón R, Viciana I, Jiménez JB, Fernández-García F, Toro-Ortiz JP, Sánchez-Yáñez E, Álvarez-Álvarez I, Andrade RJ, Robles-Díaz M, García-Cortés M. Pinazo-Bandera JM, et al. Among authors: andrade rj. Gastroenterol Rep (Oxf). 2024 Jan 22;12:goad077. doi: 10.1093/gastro/goad077. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 38264764 Free PMC article.
Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification.
Niu H, Solis-Muñoz P, García-Cortés M, Sanabria-Cabrera J, Robles-Diaz M, Romero-Flores R, Bonilla-Toyos E, Ortega-Alonso A, Pinazo-Bandera JM, Cabello MR, Bessone F, Hernandez N, Lucena MI, Andrade RJ, Medina-Caliz I, Alvarez-Alvarez I. Niu H, et al. Among authors: andrade rj. Pharmacol Res. 2024 Jan;199:107030. doi: 10.1016/j.phrs.2023.107030. Epub 2023 Dec 8. Pharmacol Res. 2024. PMID: 38072217 Free article.
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
Medina-Cáliz I, Sanabria-Cabrera J, Villanueva-Paz M, Aukštikalnė L, Stephens C, Robles-Díaz M, Pinazo-Bandera JM, García-Cortes M, Conde I, Soriano G, Bessone F, Hernandez N, Nunes V, Paraná R, Lucena MI, Andrade RJ, Niu H, Alvarez-Alvarez I. Medina-Cáliz I, et al. Among authors: andrade rj. Arch Toxicol. 2024 Jan;98(1):303-325. doi: 10.1007/s00204-023-03630-0. Epub 2023 Dec 5. Arch Toxicol. 2024. PMID: 38051367 Free PMC article.
236 results